Alembic Ltd.

78.73 -1.07 ▼-1.3%

21 September 2023, 04:01:00 PM
Volume: 18,527

Company Profile

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.alembiclimited.com
Market Cap 2,019.33 Cr.
Enterprise Value(EV) 2,017.43 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 9.88 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 7.97 Trailing Twelve Months Ending 2023-06
Industry PE 37.95 Trailing Twelve Months Ending 2023-06
Book Value / Share 81.31 Trailing Twelve Months Ending 2023-06
Price to Book Value 0.97 Calculated using Price: 78.73
Dividend Yield 2.80 Period Ending 2023-03
No. of Shares Subscribed 25.68 Cr. 256,781,828 Shares
FaceValue 2
About Alembic Ltd.
Alembic was incorporated in 1907 as Alembic Chemical Works Company, primarily engaged in production of tinctures and alcohol at Baroda. Later the company set up distillery plant for pharmaceutical purposes at Baroda. It started manufacturing of cough syrup, vitamins, tonics and sulphur drugs.

Alembic Ltd. Delivery

Delivered Qty
Traded Qty

Alembic Ltd. Performance

1 Day
-1.34%
1 Week
-1.19%
1 Month
-0.04%
3 Month
+8.49%
6 Month
+30.76%
1 Year
+15.52%
2 Year
-31.36%
5 Year
+71.90%
10 Year
+487.54%

Alembic Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 5.58 3.71 3.21 4.18 3.58 7.08 0.75 3.60 3.52
Return on Capital Employed (%) 3.82 3.82 3.12 4.44 3.91 7.12 0.94 4.10 3.82
Return on Assets (%) 2.88 3.25 2.94 3.88 3.39 6.80 0.71 3.42 3.33

Alembic Ltd. Balance Sheet

Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 528 803 911 1,086 1,209 1,418 2,297 2,497 2,078
Non Curr. Liab. 38 15 13 14 9 7 53 68 43
Curr. Liab. 82 58 68 59 49 46 59 68 84
Minority Int.
Equity & Liab. 648 876 992 1,159 1,266 1,471 2,409 2,632 2,205
Non Curr. Assets 458 706 801 972 1,167 1,308 2,307 2,489 2,032
Curr. Assets 189 169 191 187 99 163 102 143 172
Misc. Exp. not W/O
Total Assets 648 876 992 1,159 1,266 1,471 2,409 2,632 2,205

Alembic Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 144 128 147 125 124 74 74 78 127 142
Other Income 22 29 31 37 29 94 11 89 64 66
Total Income 166 156 178 162 153 167 84 167 192 208
Total Expenditure -135 -122 -140 -114 -106 -71 -63 -64 -87 -96
PBIDT 30 35 38 48 48 97 21 103 105 112
Interest -1 0 0 0 0 0 0 0 0 0
Depreciation -6 -6 -5 -4 -3 -3 -4 -5 -7 -7
Taxation 1 -1 1 -2 -4 0 -3 -12 -6 -7
Exceptional Items -3 -6 -11 -11
PAT 24 25 27 42 41 93 14 86 81 87
Minority Interest
Share Associate 82 210 118 121 172 236 329 136 110 167
Other Related Items
Consolidated Net Profit 107 235 145 163 213 329 343 222 191 254
Adjusted EPS 4 9 5 6 8 13 13 9 7 10

Alembic Ltd. Cash Flow

Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 22 10 52 24 22 7 -2 -18 39
Cash Fr. Inv. 5 -5 -47 -22 72 57 -35 19 7
Cash Fr. Finan. -25 -5 -5 -3 -92 -6 -15 -6 -46
Net Change 2 0 0 -1 1 57 -52 -5 0
Cash & Cash Eqvt 3 2 2 1 2 59 6 1 1

Alembic Ltd. Shareholding Pattern

9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 70.88 70.88 70.88 70.88 70.88 70.88 70.88 70.88 70.88
Public 29.12 29.12 29.12 29.12 29.12 29.12 29.12 29.12 29.12
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Alembic Ltd. Announcements

Thu, 21 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith the intimation dated 21st September 2023 received from Link Intime India Private Limited Registrar and Share Transfer Agent. regarding approval of the request received for issue of Duplicate Share Certificate(s) and issue of letter of Confirmation in lieu of the physical share certificate to the registered shareholder(s) in accordance with the provisions of SEBI Circular No. SEBI/HO/MIRSD_RTAMB/P/CIR/2022/8 dated 25th January 2022.
Wed, 20 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith the intimation dated 20th September 2023 received from Link Intime Private Limited Registrar and Share Transfer Agent regarding lost/misplaced share certificate(s). of the Company for which the shareholder has requested duplicate share certificate(s).
Tue, 19 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith the intimation dated 19th September 2023 received from Link Intime India Private Limited Registrar and Share Transfer Agent regarding lost/misplaced share certificate(s) of the Company for which the shareholder has requested duplicate share certificate(s).

Alembic Ltd. Technical Scans

Thu, 21 Sep 2023
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Increase in 6 Months High Increase in 6 Months

Alembic Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 274,963.79 1,148.50 -0.4%
Divi's Laboratories Ltd. 99,404.71 3,741.45 -1.0%
Cipla Ltd. 97,455.33 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. 94,594.48 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. 72,171.99 5,023.50 +0.4%
Mankind Pharma Ltd. 69,708.40 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. 63,451.75 1,874.80 -0.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.67 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-06 67.23 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-06 31.32 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 20.07 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 108.04 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 54.38 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 50.36 1,874.80 -0.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.75 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-06 7.57 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-06 4.00 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.86 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.52 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 5.69 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.65 1,874.80 -0.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 0.02 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,874.80 -0.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,874.80 -0.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,874.80 -0.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,874.80 -0.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,874.80 -0.5%

Alembic Ltd. FAQ's

What is Alembic share price?

Can I buy Alembic shares now?

What is the Dividend Yield of Alembic?

What is the Market Cap of Alembic?

What are the key metrics to analyse Alembic?

What is the 52 Week High and Low of Alembic?

What is the trend of Alembic share price?